ESCMID membership prices are going up in two weeks for Basic, Full and Retired memberships so now is the best time to join or renew your membership with the current pricing. Members receive a variety of benefits, and you can purchase memberships for up to five years at a time. Learn more and act now to secure the best deal for ESCMID membership.

Science & Research

The Emerging Infections Subcommittee and EUCIC have organised a webinar discussing the recent hantavirus outbreak including the onset, diagnosis and clinical care. Join us this Thursday, 21 May from 15:15 - 17:00 CEST to hear about the latest developments and outcomes.

ESCMID has initiated another official study group, the ESCMID Study Group for Maternal and Child Health (ESGMATCH). The group aims to develop the understanding, prevention and management of infections affecting pregnant women, the foetus, neonates, children and adolescents. Membership is available to all ESCMID members.

Education

This course provides a comprehensive overview of how clinical breakpoints for antimicrobial agents are established using EUCAST criteria and methods. Participants will become familiar with EUCAST documents and learn how to use them effectively.

Explore the many fundamental differences between adults and children that impact on clinical decision making through a series of case-based interactive workshops during this ESCMID course which is part of the AMS Certificate 2026-2028. Learn more and register today.

Congress & Events

The abstracts accepted and presented at ESCMID Global 2026 have been collectively published in an official congress abstract book that is now available for free on our website. Congress registrants can also view all ePosters through the virtual congress platform until 31 October as part of their registration.

Guidelines & Journals

There is just under two weeks remaining for ESCMID members to send in proposals for ESCMID guidelines projects. See the overarching themes and the details for submission on our website. Submit your proposal before the deadline on 29 May.

The ESCMID Global Late Breakers series returns to Communicable. Five CMI Communications editors - Marc Bonten, Josh Davis, Angela Huttner, Anne-Grete Märtson, and Erin McCreary - handpicked five late-breaking trials presented at ESCMID Global 2026 to summarise their findings and discuss whether the results will change their practice. This is part one of the two-part series.

The Democratic Republic of the Congo declared its 17th Ebola outbreak following the confirmation of Bundibugyo virus disease, where 246 suspected cases and 80 deaths have been recorded. Uganda confirmed two imported cases, prompting the WHO to declare a Public Health Emergency of International Concern. Globally, eleven cases of Andes virus, including three deaths, occurred among passengers and crew of the MV Hondius cruise ship. In Australia, an ongoing diphtheria increase has resulted in 83 confirmed cases and the country's first related death in nearly a decade. Iraq reported 48 confirmed cases of Crimean-Congo hemorrhagic fever, including four deaths, since the start of 2026.

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the EUCAST Subcommittee

Plasmodium falciparum's converging threats to malaria control and elimination